Cytokinetics (CYTK)EVP Research & Development sold ~$303K

~$303K

Approx. value · 3,500 sh @ $86.62

154K

Holds after · shares reported

Traded

Jul 7, 2026

Filed

Jul 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 14, 2026InsiderCEO sold ~$584K of CYTK shares in the open market
2. May 19, 2026InsiderOfficer sold ~$265K of CYTK shares in the open market
3. May 27, 2026InsiderCEO sold ~$579K of CYTK shares in the open market
4. Jun 1, 2026Insider · 3 peopleInsiders: 3 sales (~$1.7M)
5. Jun 9, 2026InsiderOfficer sold ~$238K of CYTK shares in the open market
6. Jun 15, 2026InsiderCEO sold ~$528K of CYTK shares in the open market
7. Jun 23, 2026InsiderOfficer sold ~$278K of CYTK shares in the open market
8. Jun 24, 2026InsiderCFO sold ~$3.19M of CYTK shares in the open market
9. Jun 29, 2026InsiderCFO sold ~$266K of CYTK shares in the open market
10. Jun 30, 2026CongressDisclosed purchase of CYTK — reported range $1,001 - $15,000
11. Jul 1, 2026Insider · 3 peopleInsiders: 3 sales (~$2.0M)
12. Jul 7, 2026 · this disclosureInsiderOfficer sold ~$303K of CYTK shares in the open market

What came next

1. Jul 13, 2026Insider · 1 personInsiders: 2 sales (~$615K)
2. Jul 21, 2026InsiderOfficer sold ~$282K of CYTK shares in the open market
3. Jul 27, 2026InsiderCEO sold ~$607K of CYTK shares in the open market
4. Jul 30, 2026InsiderOfficer sold ~$1.12M of CYTK shares in the open market
5. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
6. Aug 10, 2026InsiderCEO sold ~$576K of CYTK shares in the open market
7. Aug 18, 2026InsiderOfficer sold ~$265K of CYTK shares in the open market
8. Aug 31, 2026Insider · 2 peopleInsiders: 2 sales (~$1.2M)
9. Sep 1, 2026InsiderDirector sold ~$357K of CYTK shares in the open market
10. Sep 8, 2026InsiderOfficer sold ~$264K of CYTK shares in the open market
11. Sep 11, 2026InsiderDirector sold ~$75K of CYTK shares in the open market
12. Sep 14, 2026InsiderCEO sold ~$551K of CYTK shares in the open market
13. Sep 15, 2026Insider · 2 peopleInsiders: 2 sales (~$6.9M)
14. Sep 22, 2026InsiderOfficer sold ~$239K of CYTK shares in the open market
15. Sep 28, 2026InsiderCEO sold ~$491K of CYTK shares in the open market
16. Oct 6, 2026InsiderOfficer sold ~$215K of CYTK shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cytokinetics

For Cytokinetics, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 11 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CYTK page.

Other recent filings by Fady Ibraham Malik, EVP Research & Development

• SEC Form 4 at Cytokinetics (CYTK)Oct 6, 2026
• SEC Form 4 at Cytokinetics (CYTK)Sep 22, 2026
• SEC Form 4 at Cytokinetics (CYTK)Sep 8, 2026
• SEC Form 4 at Cytokinetics (CYTK)Aug 18, 2026
• SEC Form 4 at Cytokinetics (CYTK)Jul 23, 2026

The full history of Fady Ibraham Malik, EVP Research & Development is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cytokinetics

• SEC Form 4Oct 6, 2026
• SEC Form 4Sep 28, 2026
• SEC Form 4Sep 22, 2026
• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 15, 2026

Everything OQRO holds on this company is on its CYTK page.